.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has shown a consistent performance in the Arizona market, particularly in the Tincture & Sublingual category, where it has maintained a steady rank of 2nd place from July through October 2025. This demonstrates a strong foothold in this category, despite a gradual decline in sales over the months. On the other hand, the brand's performance in the Topical category has seen more fluctuation, dropping from 2nd place in July and August to 3rd in September and further down to 5th in October. This downward trend in rankings, coupled with fluctuating sales figures, indicates potential challenges in maintaining its market position in the Topical category.
It is noteworthy that Chronic Health has not been able to secure a top 30 position in other states or categories during the same period, which could be seen as a limitation in its market reach or category diversification. The absence of rankings in additional states hints at a strong regional focus or possibly a need for strategic expansion to capture a broader market. The insights from Arizona serve as a valuable lens to assess the brand's strengths and areas for growth, especially in diversifying its product appeal beyond its current stronghold in Tinctures & Sublinguals.
Competitive Landscape
In the Arizona topical cannabis market, Chronic Health has experienced notable fluctuations in its competitive standing over the past few months. Initially holding a strong position at rank 2 in July and August 2025, Chronic Health saw a decline to rank 3 in September and further dropped to rank 5 by October. This decline coincides with the consistent performance of iLava, which maintained a steady rank 4 throughout the same period, and the resurgence of Tru Infusion, which improved its rank from 5 in August and September to reclaim the 3rd spot in October. Despite these challenges, Chronic Health's sales in October showed a recovery from September's dip, indicating potential resilience in its market strategy. Meanwhile, Gramz and DermaFreeze remained outside the top 5, with Gramz showing a positive trend by moving up from rank 7 in August and September to rank 6 in October, while DermaFreeze fell out of the top 20 by October. These dynamics highlight the competitive pressures Chronic Health faces and the importance of strategic adjustments to regain its earlier market position.
Notable Products
In October 2025, the top-performing product for Chronic Health was the Indica THC Glycerin Tincture (100mg THC, 1oz), maintaining its number one rank consistently since July 2025 with sales of 452 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) moved up to the second position, showing a steady increase in popularity over the months. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) slipped to third place, experiencing a significant drop in sales compared to previous months. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) and the CBD/THC 1:1 Pain Relief Ointment (45mg CBD, 45mg THC) held steady at fourth and fifth ranks, respectively. These rankings highlight a strong preference for tinctures, with slight fluctuations in consumer demand for topical products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
